EUVIMEDEUVIMED entdecken
Crossref

Relationship Between Serum Endocan Levels and Other Predictors of Endothelial Dysfunction in Obese Women

Filiz Mercantepe iD, Serap Baydur Sahin, Medine Cumhur Cure, Zakir Karadag

Angiology · 2023-11 · 74 (10) · 948-957

DOI: 10.1177/00033197221129358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angiology, online erschienen am 11.11.2022. Verfasst von Filiz Mercantepe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism Disease, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Recep Tayyip Erdogan Ã&z.hfl;œniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endocan, or endothelial cell-specific molecule-1 (ESM-1), is a potential inflammatory marker implicated in endothelial dysfunction. The purpose of this study was to determine the correlation between serum endocan levels and the presence and severity of endothelial dysfunction, and the relationships with serum intracellular adhesion molecule-1 (ICAM-1), adiponectin (a marker of inflammation), high sensitivity C-reactive protein (hsCRP) levels, and carotid intima-media thickness (cIMT) in obese subjects. Serum endocan, ICAM-1, adiponectin, hsCRP levels, and cIMT were evaluated in 76 obese women (BMI > 30 kg/m 2 ) and 53 controls (BMI < 25 kg/m 2 ). ICAM-1 ( P = .01), hs-CRP (p < 0.001), and cIMT ( p < .001) were significantly higher, while adiponectin ( P = .006) was significantly lower, in obese women compared with the controls. Serum endocan levels were similar between the obese (470.5 ± 171.3 pg/mL) and controls (471.9 ± 146.3 pg/mL) ( P = .732). There was no correlation between serum endocan values and the endothelial dysfunction markers, hsCRP (r = −.021), ICAM-1 (r = −.054), adiponectin (r = .113), or cIMT (r = −.060) in obesity. Endocan is not a suitable marker of endothelial dysfunction in the context of obesity. More research is required to evaluate the role of endocan in the regulation of inflammatory processes in obesity.

Schlagwörter

Stichwörter der Autor:innen

endocanendothelial dysfunctionobesity

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism Disease, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey.
  • Department of Endocrinology and Metabolism Disease, Medistate Kavacik Hospital, Istanbul, Turkey.
  • Department of Biochemistry, Istanbul Laboratory, Istanbul, Turkey.
  • Department of Cardiology, Systems Hospital, Kayseri, Turkey.

ORCID-Profile: Filiz Mercantepe

Förderung

  • Recep Tayyip Erdogan Ã&z.hfl;œniversitesi

Zitieren

APA

Mercantepe, F., Baydur Sahin, S., Cumhur Cure, M., & Karadag, Z. (2023). Relationship Between Serum Endocan Levels and Other Predictors of Endothelial Dysfunction in Obese Women. Angiology, 74(10), 948-957. https://doi.org/10.1177/00033197221129358

Vancouver

Mercantepe F, Baydur Sahin S, Cumhur Cure M, Karadag Z. Relationship Between Serum Endocan Levels and Other Predictors of Endothelial Dysfunction in Obese Women. Angiology. 2023;74(10):948-957. doi:10.1177/00033197221129358

BibTeX
@article{Mercantepe2023,
  author = {Mercantepe, Filiz and Baydur Sahin, Serap and Cumhur Cure, Medine and Karadag, Zakir},
  title = {Relationship Between Serum Endocan Levels and Other Predictors of Endothelial Dysfunction in Obese Women},
  journal = {Angiology},
  year = {2023},
  volume = {74},
  number = {10},
  pages = {948--957},
  doi = {10.1177/00033197221129358}
}
Kostenlos starten →